Evidence map›Paper›PMID 27528677›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Link of a ubiquitous human coronavirus to dromedary camels.

Victor M Corman, Isabella Eckerle, Ziad A Memish, Anne M Liljander, Ronald Dijkman, Hulda Jonsdottir, Kisi J Z Juma Ngeiywa, Esther Kamau, Mario Younan, Malakita Al Masri and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 165 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 8 countries.

Victor M CormanUniversity of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, partner site Bonn-Cologne, Germany;ORCID 0000-0002-3605-0136
Isabella EckerleUniversity of Bonn Medical Centre, 53127 Bonn, Germany;
Ziad A MemishCollege of Medicine, Alfaisal University, 11533 Riyadh, Kingdom of Saudi Arabia;
Anne M LiljanderInternational Livestock Research Institute, Nairobi, Kenya;
Ronald DijkmanDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty Bern, University of Bern, 3012 Bern, Switzerland; Federal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelhausern, Switzerland;
Hulda JonsdottirDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty Bern, University of Bern, 3012 Bern, Switzerland; Federal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelhausern, Switzerland;
Kisi J Z Juma NgeiywaMinistry of Agriculture, Livestock, and Fisheries, State Department of Livestock, Department of Veterinary Services, Nairobi, Kenya;
Esther KamauMinistry of Agriculture, Livestock, and Fisheries, State Department of Livestock, Department of Veterinary Services, Nairobi, Kenya;
Mario YounanVétérinaires Sans Frontières Germany, Nairobi, Kenya;
Malakita Al MasriMinistry of Health, 11176 Riyadh, Kingdom of Saudi Arabia;
Abdullah AssiriMinistry of Health, 11176 Riyadh, Kingdom of Saudi Arabia;
Ilona GluecksVétérinaires Sans Frontières Suisse, Nairobi, Kenya;
Bakri E MusaMinistry of Science and Communication, Khartoum, Sudan;
Benjamin MeyerUniversity of Bonn Medical Centre, 53127 Bonn, Germany;
Marcel A MüllerUniversity of Bonn Medical Centre, 53127 Bonn, Germany;
Mosaad HilaliCairo University, 12613 Giza, Egypt;
Set BornsteinNational Veterinary Institute, 75189 Uppsala, Sweden;
Ulrich WerneryCentral Veterinary Research Laboratory, Dubai, United Arab Emirates;
Volker ThielDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty Bern, University of Bern, 3012 Bern, Switzerland; Federal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelhausern, Switzerland;
Joerg JoresInternational Livestock Research Institute, Nairobi, Kenya; Institute of Veterinary Bacteriology, University of Bern, 3001 Bern, Switzerland.
Jan Felix DrexlerUniversity of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, partner site Bonn-Cologne, Germany; drexler@virology-bonn.de drosten@virology-bonn.de.
Christian DrostenUniversity of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, partner site Bonn-Cologne, Germany; drexler@virology-bonn.de drosten@virology-bonn.de.
University of Bonn · DEUniversity of Bern · CHMinistry of Agriculture Livestock and Fisheries · KEMinistry of Health · SAVétérinaires Sans Frontières Suisse · KEAlfaisal University · SACairo University · EGCentral Veterinary Research Laboratory · AEInternational Livestock Research Institute · KEMinistry of Higher Education And Scientific Research · SDSwedish Veterinary Agency · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The four human coronaviruses (HCoVs) are globally endemic respiratory pathogens. The Middle East respiratory syndrome (MERS) coronavirus (CoV) is an emerging CoV with a known zoonotic source in dromedary camels. Little is known about the origins of endemic HCoVs. Studying these viruses' evolutionary history could provide important insight into CoV emergence. In tests of MERS-CoV-infected dromedaries, we found viruses related to an HCoV, known as HCoV-229E, in 5.6% of 1,033 animals. Human- and dromedary-derived viruses are each monophyletic, suggesting ecological isolation. One gene of dromedary viruses exists in two versions in camels, full length and deleted, whereas only the deleted version exists in humans. The deletion increased in size over a succession starting from camelid viruses via old human viruses to contemporary human viruses. Live isolates of dromedary 229E viruses were obtained and studied to assess human infection risks. The viruses used the human entry receptor aminopeptidase N and replicated in human hepatoma cells, suggesting a principal ability to cause human infections. However, inefficient replication in several mucosa-derived cell lines and airway epithelial cultures suggested lack of adaptation to the human host. Dromedary viruses were as sensitive to the human type I interferon response as HCoV-229E. Antibodies in human sera neutralized dromedary-derived viruses, suggesting population immunity against dromedary viruses. Although no current epidemic risk seems to emanate from these viruses, evolutionary inference suggests that the endemic human virus HCoV-229E may constitute a descendant of camelid-associated viruses. HCoV-229E evolution provides a scenario for MERS-CoV emergence.

Indexed as

AnimalsBase SequenceCaco-2 CellsCamelusCell LineCell Line, TumorCells, CulturedChlorocebus aethiopsCoronavirusCoronavirus InfectionsEndemic DiseasesHumansKenyaMiddle East Respiratory Syndrome CoronavirusPhylogenySaudi Arabiacoronavirusecologyevolutionlivestockzoonotic diseases

Identifiers

PMID27528677
PMCPMC5024591
OpenAlexW2508433652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.